SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/01/16 Orthofix Medical Inc. 10-Q 6/30/16 56:5.6M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 488K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 11: R1 Document and Entity Information HTML 39K 12: R2 Condensed Consolidated Balance Sheets HTML 89K 13: R3 Condensed Consolidated Balance Sheets HTML 30K (Parenthetical) 14: R4 Condensed Consolidated Statements of Operations HTML 133K and Comprehensive Income (Loss) 15: R5 Condensed Consolidated Statements of Cash Flows HTML 62K 16: R6 Nature of operations, basis of presentation and HTML 32K recently issues accounting pronouncements 17: R7 Inventories HTML 46K 18: R8 Long-term debt HTML 23K 19: R9 Derivative instruments HTML 68K 20: R10 Fair value measurements HTML 180K 21: R11 Accumulated other comprehensive loss HTML 71K 22: R12 Earnings per share HTML 58K 23: R13 Share-based compensation HTML 26K 24: R14 Income taxes HTML 25K 25: R15 Business segment information HTML 207K 26: R16 Contingencies HTML 48K 27: R17 Share repurchase plan HTML 22K 28: R18 Nature of operations, basis of presentation and HTML 32K recently issues accounting pronouncements (Policies) 29: R19 Inventories (Tables) HTML 46K 30: R20 Derivative instruments (Tables) HTML 65K 31: R21 Fair value measurements (Tables) HTML 172K 32: R22 Accumulated other comprehensive loss (Tables) HTML 67K 33: R23 Earnings per share (Tables) HTML 55K 34: R24 Business segment information (Tables) HTML 203K 35: R25 Nature of operations, basis of presentation and HTML 21K recently issues accounting pronouncements - Additional Information (Detail) 36: R26 Inventories - Schedule of Inventories (Detail) HTML 31K 37: R27 Long-Term Debt - Additional Information (Detail) HTML 35K 38: R28 Derivative Instruments - Schedule of Fair Values HTML 28K of Derivative Instruments (Detail) 39: R29 Derivative Instruments - Schedule of Gain (Loss) HTML 25K Recognized in Other Comprehensive Income (Loss) (Detail) 40: R30 Fair Value Measurements - Schedule of Financial HTML 53K Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) 41: R31 Fair Value Measurements - Additional Information HTML 42K (Detail) 42: R32 Fair Value Measurements - Schedule of HTML 28K Reconciliation of Debt Securities (Detail) 43: R33 Accumulated Other Comprehensive Loss - Components HTML 46K of Changes in Accumulated Other Comprehensive Loss (Detail) 44: R34 Accumulated Other Comprehensive Loss - Components HTML 35K of Changes in Accumulated Other Comprehensive Loss (Parenthetical) (Detail) 45: R35 Earnings Per Share - Schedule of Reconciliation of HTML 29K Weighted Average Shares Used in Calculation of Basic and Diluted Net (Loss) Income Per Share (Detail) 46: R36 Earnings Per Share - Additional Information HTML 28K (Detail) 47: R37 Share-based Compensation - Additional Information HTML 31K (Detail) 48: R38 Income Taxes - Additional Information (Detail) HTML 27K 49: R39 Business Segment Information - Additional HTML 20K Information (Detail) 50: R40 Business Segment Information - Schedule of Net HTML 34K Sales by SBU Reporting Segment (Detail) 51: R41 Business Segment Information - Summary of Net HTML 53K Margin as Gross Profit Less Sales and Marketing Expense by SBU Reporting Segment (Detail) 52: R42 Contingencies - Additional Information (Detail) HTML 41K 53: R43 Share Repurchase Plan - Additional Information HTML 34K (Detail) 55: XML IDEA XML File -- Filing Summary XML 99K 54: EXCEL IDEA Workbook of Financial Reports XLSX 50K 5: EX-101.INS XBRL Instance -- ofix-20160630 XML 1.55M 7: EX-101.CAL XBRL Calculations -- ofix-20160630_cal XML 116K 8: EX-101.DEF XBRL Definitions -- ofix-20160630_def XML 272K 9: EX-101.LAB XBRL Labels -- ofix-20160630_lab XML 639K 10: EX-101.PRE XBRL Presentations -- ofix-20160630_pre XML 492K 6: EX-101.SCH XBRL Schema -- ofix-20160630 XSD 104K 56: ZIP XBRL Zipped Folder -- 0001564590-16-021905-xbrl Zip 94K
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Orthofix International N.V. (“Orthofix”) on Form 10-Q for the quarterly period ended June 30, 2016, (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, Bradley R. Mason, Chief Executive Officer and President of Orthofix, and Doug Rice, Chief Financial Officer, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Orthofix. |
Dated: August 1, 2016 |
/s/ BRADLEY R. MASON |
|
|
Name: |
|
|
Title: |
President and Chief Executive Officer |
|
|
|
Dated: August 1, 2016 |
/s/ DOUG RICE |
|
|
Name: |
|
|
Title: |
Chief Financial Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/1/16 | 8-K | ||
For Period end: | 6/30/16 | |||
List all Filings |